Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing phase 4 study of tazarotene + betamethasone cream for chronic plaque psoriasis
ChiCTR1900026812Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tazarotene and betamethasone dipropionate in plaque psoriasis, sponsored by Peking Union Medical College Hospital. Primary endpoint: Overall adverse reaction rate. Started Aug 2016; status: completed.
02
Drugs
tazarotenebetamethasone dipropionate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR1900026812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026812.